Interferon Beta-1B is a medication used to treat certain types of multiple sclerosis (MS). It helps reduce the frequency and severity of relapses in people with relapsing forms of MS. This medication can slow down the progression of the disease and improve the quality of life for individuals living with MS.
For A Single Demyelinating Event With An Active Inflammatory Process (if Severe And Require Intravenous Corticosteroid And Patient At High Risk Of Developing Multiple Sclerosis), For Relapsing, Remitting Multiple Sclerosis (at Least Two Attacks Of Neurological Dysfunction) Who Are Able To Walk Unaided:
By Sc Inj:
Adults & Children Above 12: Initially 62.5 Mcg On Alternate Days Increasing Slowly Over A Period Of 19 Days To 250 Microgram On Alternate Days. Discontinue If No Response (e.g. Steady Progression Of Disability For 6 Months Or Treatment With At Least 3 Courses Of Acth Or Corticosteroids In 1 Yr). Reassess After 2 Yr.
Children: Under 12 Yr: Not Recommended.
Content
Inj 300 Mcg: Interferon Beta-1 B 300 Mcg (9.6 Mil-lion Unit); Powder In Vial With Diluent.
Inj 250 Mcg: Interferon Beta-1b 250 Mcg (8 Million Unit); Powder In Vial With Diluent.
Pregnancy
Avoid, Use Only When No Safer Alternative Exists For A Serious Problem.
Stability
Single-subtype Recombinant
Contra Indications
History Of Severe Depression Or Suicidal Tendencies, Decompensated Liver Disease, Uncontrolled Epilepsy. Ensure Adequate Contraception.
Precautions
History Of Severe Depression Or Suicidal Tendencies, Decompensated Liver Disease, Uncontrolled Epilepsy. Ensure Adequate Contraception.